Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;29(3):316-327.
doi: 10.1002/pds.4930. Epub 2020 Feb 4.

Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden

Gabriella Bröms  1 , Helle Kieler  2 , Anders Ekbom  3 , Mika Gissler  4 , Karin Hellgren  3 , Anna-Maria Lahesmaa-Korpinen  5 , Lars Pedersen  6 , Marcus Schmitt-Egenolf  7 , Henrik T Sørensen  6 , Fredrik Granath  3
Affiliations

Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden

Gabriella Bröms et al. Pharmacoepidemiol Drug Saf. 2020 Mar.

Abstract

Purpose: To study the risk of preterm birth, caesarean section, and small for gestational age after anti-tumor necrosis factor agent treatment (anti-TNF) in pregnancy.

Methods: Population-based study including women with inflammatory bowel disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis, and their infants born 2006 to 2013 from the national health registers in Denmark, Finland, and Sweden. Women treated with anti-TNF were compared with women with nonbiologic systemic treatment. Adalimumab, etanercept, and infliximab were compared pairwise. Continuation of treatment in early pregnancy was compared with discontinuation. Odds ratios with 95% confidence intervals were calculated in logistic regression models adjusted for country and maternal characteristics.

Results: Among 1 633 909 births, 1027 infants were to women treated with anti-TNF and 9399 to women with nonbiologic systemic treatment. Compared with non-biologic systemic treatment, women with anti-TNF treatment had a higher risk of preterm birth, odds ratio 1.61 (1.29-2.02) and caesarean section, 1.57 (1.35-1.82). The odds ratio for small for gestational age was 1.36 (0.96-1.92). In pairwise comparisons, infliximab was associated with a higher risk of severely small for gestational age for inflammatory joint and skin diseases but not for inflammatory bowel disease. Discontinuation of anti-TNF had opposite effects on preterm birth for inflammatory bowel disease and inflammatory joint and skin diseases.

Conclusions: Anti-TNF agents were associated with increased risks of preterm birth, caesarean section, and small for gestational age. However, the diverse findings across disease groups may indicate an association related to the underlying disease activity, rather than to agent-specific effects.

Keywords: TNF inhibitor; adalimumab; anti-TNF; etanercept; inflammatory bowel disease; infliximab; pregnancy; rheumatoid arthritis.

PubMed Disclaimer

References

REFERENCES

    1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54 e42; quiz e30. https://doi.org/10.1053/j.gastro.2011.10.001 [published Online First: 2011/10/18]
    1. Kvien TK, Uhlig T, Odegard S, Heiberg MS. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci. 2006;1069(1):212-222. https://doi.org/10.1196/annals.1351.019 [published Online First: 2006/07/21]
    1. Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford). 2014;53(4):650-657. https://doi.org/10.1093/rheumatology/ket387 [published Online First: 2013/12/11]
    1. Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(21):2095-2096. https://doi.org/10.1056/NEJMc1704342 [published Online First: 2017/05/26]
    1. Han JH, Lee JH, Han KD, et al. Epidemiology and medication trends in patients with psoriasis: a nationwide population-based cohort study from Korea. Acta Derm Venereol. 2017;98(4):396-400. https://doi.org/10.2340/00015555-2877 [published Online First: 2017/12/22]

Publication types

LinkOut - more resources